Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease [2]

Clinical Endocrinology

Volumn 63, Issue 1, 2005, Pages 118-119

  Cannavo S ^a   Arosio, M ^b,c   Almoto, B ^a   Dall'Asta, C ^b   Ambrosi, B ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c San Giuseppe Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; ROSIGLITAZONE;

CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LETTER; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADRENOCORTICOTROPIC HORMONE; HUMANS; HYDROCORTISONE; PITUITARY ACTH HYPERSECRETION; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 22044457755     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02285.x     Document Type: Letter

References (5)

1. Hull, S.S.A., Sheridan, B. & Atkinson, A.B. (2005) Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary dependent Cushing's syndrome. Clinical Endocrinology, 62, 259-261.
2. Heaney, A.P., Fernando, M., Yong, W.H. & Melmed, S. (2002) Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenoma. Nature Medicine, 8, 1281-1287.
3. Ambrosi, B., Dall'Asta, C., Cannavò, S., Libè, R., Vigo, T., Epaminonda, P., Chiodini, L., Ferrero, S., Trimarchi, F., Arosio, M. & Beck-Peccoz, P. (2004) Effects of chronic administration of PPAR-γ receptor ligand rosiglitazone in Cushing's disease. European Journal of Endocrinology, 151, 173-178.
4. Pecori Giraldi, F., Scaroni, C., Arvat, E., De Martin, M., Giordano, R., Albinger, N., Leao, A.A.S., Picu, A., Mantero, F. & Cavagnini, F. (2004) Effect of protracted treatment with rosiglitazone, a PPAR-γ agonist, in patients with Cushing's disease. A pilot study. Proceedings of the 11th ENEA Meeting, Sorrento, Italy, April 24-27, O2.4, 25 (Abstract).
5. Suri, D. & Weiss, R.E. (2005) Effect of pioglitazone on ACTH and cortisol secretion in Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 90, 1340-1346.